Standardization of flow cytometric minimal residual disease assessment in international clinical trials - a feasibility study from the European Myeloma Network

Davine Hofste op Bruinink, S Oliva, L Rihova, A Schmitz, M Gilestro, Jeroen te Marvelde, R Kralova, H Høholt, A. Broijl, HE Johnsen, R Hajek, M Boccadoro, Pieter Sonneveld, P Omedè, Vincent van der Velden

Research output: Contribution to journalArticleAcademicpeer-review

7 Citations (Scopus)
Original languageEnglish
JournalHaematologica
VolumeOnline ahe
DOIs
Publication statusPublished - 2020

Cite this